NCT06458764 Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
| NCT ID | NCT06458764 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Candiolo Cancer Institute - IRCCS |
| Condition | Breast Cancer Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-05-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Eligibility Criteria
Inclusion Criteria: * women aged ≥18 and ≤ 55 * who underwent surgery for early stage breast cancer * taking endocrine therapy for at least 3 months * providing an informed consent and completing the study questionnaires. Exclusion Criteria: * withdrawal of the informed consent, at any time
Frequently Asked Questions
Who can join the NCT06458764 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Breast Cancer Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06458764 currently recruiting?
Yes, NCT06458764 is actively recruiting participants. Visit ClinicalTrials.gov or contact Candiolo Cancer Institute - IRCCS to inquire about joining.
Where is the NCT06458764 trial being conducted?
This trial is being conducted at Torino, Italy.
Who is sponsoring the NCT06458764 clinical trial?
NCT06458764 is sponsored by Candiolo Cancer Institute - IRCCS. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.